![Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis and Ischemia, Acute Coronary Syndrome Testing Strategy Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis and Ischemia, Acute Coronary Syndrome Testing Strategy](https://img.medscapestatic.com/pi/meds/ckb/01/303801tn.jpg)
Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis and Ischemia, Acute Coronary Syndrome Testing Strategy
![Frontiers | A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation Frontiers | A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation](https://www.frontiersin.org/files/Articles/682538/fcvm-08-682538-HTML-r1/image_m/fcvm-08-682538-g001.jpg)
Frontiers | A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
![Advances in Respiratory Medicine | Free Full-Text | Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery Hemodynamics Advances in Respiratory Medicine | Free Full-Text | Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery Hemodynamics](https://pub.mdpi-res.com/arm/arm-90-00055/article_deploy/html/images/arm-90-00055-g001.png?1669199262)
Advances in Respiratory Medicine | Free Full-Text | Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery Hemodynamics
![The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: JACC: Advances Expert Panel | JACC: Advances The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: JACC: Advances Expert Panel | JACC: Advances](https://www.jacc.org/cms/asset/354955d0-9dc3-41ea-9c01-ffcd4a53aa81/fx1.jpg)
The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: JACC: Advances Expert Panel | JACC: Advances
![Life | Free Full-Text | Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 1 Life | Free Full-Text | Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 1](https://pub.mdpi-res.com/life/life-11-00914/article_deploy/html/images/life-11-00914-g001-550.jpg?1630656952)
Life | Free Full-Text | Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 1
![Which Marker is the Best for Assessing Acute Heart Failure or Does it Matter? - American College of Cardiology Which Marker is the Best for Assessing Acute Heart Failure or Does it Matter? - American College of Cardiology](https://www.acc.org/-/media/Non-Clinical/Migration-Content/Hot-Topics/Cardiac-Biomarkers/Which-Marker-is-the-Best-for-Assessing-Acute-Heart-Failure-or-Does-it-Matter/hottopic_NP_Indications_fig1.jpg?la=en&hash=3C462FD55DD2A7833BC0C029B467614388573876)
Which Marker is the Best for Assessing Acute Heart Failure or Does it Matter? - American College of Cardiology
![Risk Stratification in Acute Normotensive Pulmonary Embolism– Role of Echocardiography Imaging and Biomarkers Risk Stratification in Acute Normotensive Pulmonary Embolism– Role of Echocardiography Imaging and Biomarkers](https://jiaecho.org/articles/2022/6/1/images/JIndianAcadEchocardiogrCardiovascImaging_2022_6_1_45_332708_t5.jpg)
Risk Stratification in Acute Normotensive Pulmonary Embolism– Role of Echocardiography Imaging and Biomarkers
![Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) - Meijers - 2021 - European Journal of Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) - Meijers - 2021 - European Journal of](https://onlinelibrary.wiley.com/cms/asset/5bb256be-2396-44e9-b4dc-f68c8f68ebfb/ejhf2346-toc-0001-m.jpg)
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) - Meijers - 2021 - European Journal of
Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism | PLOS ONE
![between the levels of cardiac biomarkers and the values of different... | Download Scientific Diagram between the levels of cardiac biomarkers and the values of different... | Download Scientific Diagram](https://www.researchgate.net/publication/259130283/figure/tbl3/AS:669647451983896@1536667802766/between-the-levels-of-cardiac-biomarkers-and-the-values-of-different-Echo-variables-in.png)
between the levels of cardiac biomarkers and the values of different... | Download Scientific Diagram
![Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology | JACC: CardioOncology Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology | JACC: CardioOncology](https://www.jacc.org/cms/asset/d9b5ee4c-4a9f-4386-b3be-b0b3b9a5d88c/gr1.jpg)
Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology | JACC: CardioOncology
![The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis | Critical Care | Full Text The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fcc10119/MediaObjects/13054_2010_Article_9393_Fig2_HTML.jpg)
The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis | Critical Care | Full Text
![Medicina | Free Full-Text | Intermediate-Risk Pulmonary Embolism: A Review of Contemporary Diagnosis, Risk Stratification and Management Medicina | Free Full-Text | Intermediate-Risk Pulmonary Embolism: A Review of Contemporary Diagnosis, Risk Stratification and Management](https://pub.mdpi-res.com/medicina/medicina-58-01186/article_deploy/html/images/medicina-58-01186-g001.png?1662537611)
Medicina | Free Full-Text | Intermediate-Risk Pulmonary Embolism: A Review of Contemporary Diagnosis, Risk Stratification and Management
![Heart-type fatty acid binding protein (H-FABP): early marker of acute cardiac syndrome and risk stratification in pulmonary embolism. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc. Heart-type fatty acid binding protein (H-FABP): early marker of acute cardiac syndrome and risk stratification in pulmonary embolism. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.](https://www.advimmuno.com/wp-content/uploads/2017/05/H-FABP-700x320.jpg)
Heart-type fatty acid binding protein (H-FABP): early marker of acute cardiac syndrome and risk stratification in pulmonary embolism. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.
![Risk stratification in normotensive acute pulmonary embolism patients: focus on the intermediate–high risk subgroup - Ana Rita Santos, Pedro Freitas, Jorge Ferreira, Afonso Oliveira, Mariana Gonçalves, Daniel Faria, João Bicho Augusto, Joana Risk stratification in normotensive acute pulmonary embolism patients: focus on the intermediate–high risk subgroup - Ana Rita Santos, Pedro Freitas, Jorge Ferreira, Afonso Oliveira, Mariana Gonçalves, Daniel Faria, João Bicho Augusto, Joana](https://journals.sagepub.com/cms/10.1177/2048872619846506/asset/images/large/10.1177_2048872619846506-fig1.jpeg)